Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Argus Health
Cerilliant
Daiichi Sankyo
Harvard Business School
Baxter
Healthtrust
Chinese Patent Office

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017546

« Back to Dashboard

NDA 017546 describes NIPRIDE, which is a drug marketed by Roche and Exela Pharma Scs Llc and is included in two NDAs. Additional details are available on the NIPRIDE profile page.

The generic ingredient in NIPRIDE is sodium nitroprusside. There are one thousand four hundred and twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
Summary for 017546
Tradename:NIPRIDE
Applicant:Roche
Ingredient:sodium nitroprusside
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Cipla
Federal Trade Commission
Healthtrust
Cerilliant
Fish and Richardson
US Army
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.